missenseVarianten

Missense Varianten, or missense mutations, are nucleotide changes in which a single base substitution alters a codon so that it encodes a different amino acid in the resulting protein. Such substitutions can affect protein function in various ways, depending on the properties of the substituted amino acid, the location within the protein, and the protein’s overall structure. Consequences range from benign to pathogenic, and many missense variants remain of uncertain significance.

In the functional landscape, missense variants may disrupt catalytic activity, destabilize folding, alter protein stability, or modify interactions with other molecules. They are a common cause of inherited diseases and can also contribute to cancer by activating oncogenes or inactivating tumor suppressors. In pharmacogenomics, missense changes can influence drug binding and metabolic pathways, affecting treatment response. The impact of a given variant is highly context-dependent and often requires integration of genetic, biochemical, and clinical information.

Detection and interpretation rely on DNA sequencing and standardized nomenclature, with protein-level representations such as p.[Ala123Val] and nucleotide-level c.[?] annotations. Public databases like ClinVar, gnomAD, and COSMIC store missense variant data, including estimated frequencies and clinical significance. Computational prediction tools (for example, SIFT, PolyPhen-2, CADD) provide rapid assessments but are not definitive; experimental validation and segregation or functional studies are frequently needed. Classification schemes typically include pathogenic, likely pathogenic, benign, likely benign, and variant of uncertain significance, guiding clinical decision-making and research prioritization.